Alicia Lacoma

researcher

Alicia Lacoma is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0002-2049-3872
P1053ResearcherIDH-8516-2017
P1153Scopus author ID22935190200

P69educated atAutonomous University of BarcelonaQ43452
P734family nameLacomaQ126924936
LacomaQ126924936
LacomaQ126924936
P735given nameAliciaQ13232504
AliciaQ13232504
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q58924825AID TB resistance line probe assay for rapid detection of resistant Mycobacterium tuberculosis in clinical samples
Q36347129Accessory gene regulator (Agr) functionality in Staphylococcus aureus derived from lower respiratory tract infections.
Q50883692Adrenomedullin refines mortality prediction by the BODE index in COPD: the "BODE-A" index.
Q113242280Advances in diagnostic tools for respiratory tract infections. From tuberculosis to COVID19: changing paradigms?
Q40290315Apoptosis, Toll-like, RIG-I-like and NOD-like Receptors Are Pathways Jointly Induced by Diverse Respiratory Bacterial and Viral Pathogens
Q28068701Bacteria in the respiratory tract-how to treat? Or do not treat?
Q57331386Characterization of clinically relevant model bacterial strains of Pseudomonas aeruginosa for anti-biofilm testing of materials
Q42398993Correction for Molina-Moya et al., Evaluation of GenoFlow DR-MTB Array Test for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis
Q44449056Correlation of inflammatory and cardiovascular biomarkers with pneumonia severity scores.
Q58924857Detection of Legionella antigen in nonconcentrated and concentrated urine samples by a new immunochromatographic assay
Q41262974Diagnostic accuracy study of multiplex PCR for detecting tuberculosis drug resistance.
Q89629355E-cigarettes: Effects in phagocytosis and cytokines response against Mycobacterium tuberculosis
Q58924847Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis
Q39576968Evaluation of GenoFlow DR-MTB Array Test for Detection of Rifampin and Isoniazid Resistance in Mycobacterium tuberculosis
Q33496134Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers
Q40413348Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia.
Q51244071Exertional hypoxemia in stable COPD is common and predicted by circulating proadrenomedullin.
Q40349308GenoType MTBDRsl for molecular detection of second-line-drug and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples.
Q33767082IFN-γ response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection.
Q55506706IFNΛ3/4 locus polymorphisms and IFNΛ3 circulating levels are associated with COPD severity and outcomes.
Q34306108Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis
Q58924832Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment
Q38695997Investigating intracellular persistence of Staphylococcus aureus within a murine alveolar macrophage cell line.
Q45355121Lack of impact of human immunodeficiency virus infection on the outcome of lymphoma patients transferred to the intensive care unit.
Q36571460Mannose-binding lectin protein and its association to clinical outcomes in COPD: a longitudinal study
Q90866319Microbiological Progress in Patients with Bronchial Infection with Pseudomonas aeruginosa Treated with Nebulised Colistin
Q58924861Midregional pro-atrial natriuretic peptide as a prognostic marker in pneumonia
Q38672446Molecular Characterization of Mycobacterium tuberculosis Strains with TB-SPRINT.
Q94546351Novel intracellular antibiotic delivery system against Staphylococcus aureus: cloxacillin-loaded poly(d,l-lactide-co-glycolide) acid nanoparticles
Q89447847Persistent Isolation of Staphylococcus aureus in Mechanically-ventilated Patients: Impact of Host-Pathogen Factors on Outcome
Q40786706Prognostic assessment in COPD without lung function: the B-AE-D indices.
Q42339203PyroTyping, a novel pyrosequencing-based assay for Mycobacterium tuberculosis genotyping
Q41062404Pyrosequencing for rapid detection of Mycobacterium tuberculosis second-line drugs and ethambutol resistance.
Q35273474Pyrosequencing for rapid molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical specimens
Q58924852Quantitative evaluation of T-cell response after specific antigen stimulation in active and latent tuberculosis infection in adults and children
Q58924837Relación entre los valores séricos de procalcitonina y las complicaciones y supervivencia de pacientes con hemopatías malignas ingresados en una Unidad de Vigilancia Intensiva
Q91296876Serum levels of hyaluronic acid are associated with COPD severity and predict survival
Q58924838Specific Mycobacterium tuberculosis T cell responses to RD1-selected peptides for the monitoring of anti-tuberculosis therapy
Q58924854T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment
Q47799954Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
Q47733852Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD.
Q40116434Use of IFN-γ and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases.
Q51254303Use of interferon-gamma release assays to calculate the annual risk of tuberculosis infection.
Q58924843Usefulness of mid regional pro-atrial natriuretic peptide in the exacerbations of chronic obstructive pulmonary disease
Q34721302Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease
Q82462199[Biomarkers and suspicion of infection in emergency departments]
Q84034101[Importance of biomarkers in diagnosis, prognosis and new therapies in infectious diseases]
Q54495721[Utility of molecular biology in the microbiological diagnosis of mycobacterial infections].

Search more.